SIRT1 and cancer: Resveratrol deacetylates SIRT1 and activates hepatic Liver Kinase B1 (LKB1), leading to an increase in AMPK activity, which stimulates energy catabolism and improves cellular NAD+ levels, resulting in cancer inhibition 224.